Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind adjuvant study of nivolumab with postoperative chemotherapy in gastric cancer
CTR20171150Phase 3Suspended
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of nivolumab in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Bristol Myers Squibb. Started Jul 2018; status: suspended.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on CTR20171150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171150.